GGrantIndex
← Leaderboards

Benjamin P Linas

Massachusetts General Hospital

$16,281,715
Attributed
$20,673,385
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,673,385 · 8

By mechanism

R01$8,435,853 · 2
U24$6,550,146 · 1
T32$3,190,280 · 1
P30$1,774,572 · 2
K01$672,722 · 1
R13$49,812 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Policies

Research focus

PoliciesInnovationModels And SimulationCaringCostSimulationPharmaceutical PreparationsFundingResourcesHealth EconomicsResearch PersonnelSubstance Use DisorderHepatitis C VirusEnsureCommunitiesOverdoseEconomicsOpioid Use DisorderProgramsPublic HealthCare DeliveryMedicalCosts And BenefitsPrevent

Grant awards (39)

HEAL Data2Action Modeling and Economic Resource Center$1,562,051
U24 · FY2025 · DA
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$793,161
R01 · FY2025 · DA · contact PI
BU Clinical HIV/AIDS Research Training Program (BU-CHART$551,611
T32 · FY2025 · AI · contact PI
Population Data and Modeling Core$550,656
P30 · FY2025 · DA · contact PI
Substance Use Modeling Consortium Workshop to Support the Public Health Response to the Overdose Crisis in North America$24,856
R13 · FY2025 · DA · contact PI
HEAL Data2Action Modeling and Economic Resource Center$1,599,903
U24 · FY2024 · DA
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$866,750
R01 · FY2024 · DA · contact PI
BU Clinical HIV/AIDS Research Training Program (BU-CHART$542,752
T32 · FY2024 · AI · contact PI
Substance Use Modeling Consortium Workshop to Support the Public Health Response to the Overdose Crisis in North America$24,956
R13 · FY2024 · DA · contact PI
HEAL Data2Action Modeling and Economic Resource Center$1,632,231
U24 · FY2023 · DA
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$895,767
R01 · FY2023 · DA · contact PI
BU Clinical HIV/AIDS Research Training Program (BU-CHART$488,729
T32 · FY2023 · AI · contact PI
HEAL Data2Action Modeling and Economic Resource Center$1,755,961
U24 · FY2022 · DA
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$686,510
R01 · FY2022 · DA · contact PI
BU Clinical HIV/AIDS Research Training Program (BU-CHART$249,697
T32 · FY2022 · AI · contact PI
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$701,001
R01 · FY2021 · DA · contact PI
BU Clinical HIV/AIDS Research Training Program (BU-CHART$386,763
T32 · FY2021 · AI · contact PI
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$716,684
R01 · FY2020 · DA · contact PI
BU Clinical HIV/AIDS Research Training Program$223,690
T32 · FY2020 · AI · contact PI
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$733,883
R01 · FY2019 · DA · contact PI
BU Clinical HIV/AIDS Research Training Program$385,184
T32 · FY2019 · AI · contact PI
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core)$199,888
P30 · FY2019 · DA · contact PI
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$177,998
R01 · FY2019 · DA · contact PI
Researching Effective Strategies to Prevent Opioid Death (RESPOND)$788,879
R01 · FY2018 · DA · contact PI
BU Clinical HIV/AIDS Research Training Program$361,854
T32 · FY2018 · AI · contact PI
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core)$199,888
P30 · FY2018 · DA · contact PI
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core)$332,780
P30 · FY2017 · DA · contact PI
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core)$249,656
P30 · FY2016 · DA · contact PI
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care$612,390
R01 · FY2015 · DA · contact PI
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core)$241,704
P30 · FY2015 · DA · contact PI
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care$486,374
R01 · FY2014 · DA · contact PI
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care$89,642
R01 · FY2014 · DA · contact PI
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care$450,014
R01 · FY2013 · DA · contact PI
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care$436,800
R01 · FY2012 · DA · contact PI
Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs$128,898
K01 · FY2011 · AI · contact PI
Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs$136,375
K01 · FY2010 · AI · contact PI
Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs$136,094
K01 · FY2009 · AI · contact PI
Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs$135,815
K01 · FY2008 · AI · contact PI
Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs$135,540
K01 · FY2007 · AI · contact PI